Which injected antiosteoporotic medication is worth paying for? A cost-effectiveness analysis of teriparatide, zoledronate, ibandronate, and denosumab for postmenopausal osteoporotic women in China : Menopause

Secondary Logo

Journal Logo

Original Studies

Which injected antiosteoporotic medication is worth paying for? A cost-effectiveness analysis of teriparatide, zoledronate, ibandronate, and denosumab for postmenopausal osteoporotic women in China

You, Ruxu MS1; Mori, Takahiro MD, PhD2,3,4; Ke, Lei MS1; Wan, Yuansheng MS1; Zhang, Yu PhD1; Luo, Fei MS5; Feng, Da PhD6; Yu, Guangyi MS7; Liu, Jinyu MS8

Author Information
Menopause 29(2):p 210-218, February 2022. | DOI: 10.1097/GME.0000000000001911

Abstract

© 2021 by The North American Menopause Society

You can read the full text of this article if you:

Access through Ovid